Expression of TGF-β1 in our ICC series turned out to be a significant predictor of survival (P = 0.017) at univariate tests and an independent indicator of early tumour recurrence, regardless of vascular invasion. The gene discussed is TGFB1; the disease is intrahepatic cholangiocarcinoma.